Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
USD 26.3
(1.15%)
USD 26.3
(1.15%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 183.17 Million USD | 69.74% |
| 2022 | 112.22 Million USD | 43.96% |
| 2021 | 77.95 Million USD | 231.26% |
| 2020 | 23.53 Million USD | 12.11% |
| 2019 | 20.99 Million USD | 37.66% |
| 2018 | 15.24 Million USD | -0.51% |
| 2017 | 15.32 Million USD | 11.98% |
| 2016 | 13.68 Million USD | 63.75% |
| 2015 | 8.35 Million USD | 43889.47% |
| 2014 | 19 Thousand USD | 0.0% |
| 2013 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 191.65 Million USD | 0.61% |
| 2024 Q2 | 185.02 Million USD | 0.35% |
| 2023 Q2 | 177.41 Million USD | 0.39% |
| 2023 Q1 | 176.73 Million USD | 57.47% |
| 2023 Q4 | 190.5 Million USD | 0.42% |
| 2023 Q3 | 189.7 Million USD | 6.93% |
| 2023 FY | 190.5 Million USD | 69.74% |
| 2022 Q2 | 80.37 Million USD | 1.58% |
| 2022 Q4 | 112.22 Million USD | 39.48% |
| 2022 FY | 112.22 Million USD | 43.96% |
| 2022 Q1 | 79.13 Million USD | 1.51% |
| 2022 Q3 | 80.46 Million USD | 0.1% |
| 2021 Q2 | 76.46 Million USD | 268.13% |
| 2021 Q1 | 20.77 Million USD | -9.47% |
| 2021 Q3 | 76.48 Million USD | 0.02% |
| 2021 FY | 77.95 Million USD | 231.26% |
| 2021 Q4 | 77.95 Million USD | 1.92% |
| 2020 Q3 | 23.71 Million USD | 0.48% |
| 2020 FY | 23.53 Million USD | 12.11% |
| 2020 Q4 | 22.94 Million USD | -3.23% |
| 2020 Q1 | 20.38 Million USD | 0.16% |
| 2020 Q2 | 23.59 Million USD | 15.75% |
| 2019 Q4 | 20.35 Million USD | 3.06% |
| 2019 Q3 | 19.74 Million USD | -0.0% |
| 2019 Q2 | 19.75 Million USD | -1.34% |
| 2019 Q1 | 20.01 Million USD | 37.79% |
| 2019 FY | 20.99 Million USD | 37.66% |
| 2018 FY | 15.24 Million USD | -0.51% |
| 2018 Q4 | 14.52 Million USD | 0.91% |
| 2018 Q1 | 14.68 Million USD | -0.67% |
| 2018 Q2 | 14.62 Million USD | -0.36% |
| 2018 Q3 | 14.39 Million USD | -1.59% |
| 2017 FY | 15.32 Million USD | 11.98% |
| 2017 Q1 | 13.58 Million USD | 0.75% |
| 2017 Q3 | 14.91 Million USD | 14.37% |
| 2017 Q4 | 14.78 Million USD | -0.92% |
| 2017 Q2 | 13.04 Million USD | -4.0% |
| 2016 Q4 | 13.48 Million USD | 17.5% |
| 2016 FY | 13.68 Million USD | 63.75% |
| 2016 Q3 | 11.47 Million USD | 17.46% |
| 2016 Q2 | 9.77 Million USD | 2.79% |
| 2016 Q1 | 9.5 Million USD | 8.12% |
| 2015 Q1 | 610 Thousand USD | 3110.53% |
| 2015 FY | 8.35 Million USD | 43889.47% |
| 2015 Q4 | 8.79 Million USD | 0.81% |
| 2015 Q3 | 8.72 Million USD | 1.18% |
| 2015 Q2 | 8.62 Million USD | 1313.11% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | 25.09 Thousand USD | 146.77% |
| 2014 Q4 | 19 Thousand USD | -24.28% |
| 2014 Q2 | 10.16 Thousand USD | 0.0% |
| 2014 FY | 19 Thousand USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 1.32 Million USD | -13775.941% |
| BIMI International Medical Inc. | 5.45 Million USD | -3257.663% |
| China Jo-Jo Drugstores, Inc. | 43.21 Million USD | -323.813% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 190.5 Million USD | 3.848% |
| Leafly Holdings, Inc. | 29.08 Million USD | -529.782% |
| Leafly Holdings, Inc. | 29.08 Million USD | -529.782% |
| LifeMD, Inc. | 18.93 Million USD | -867.508% |
| LifeMD, Inc. | 18.93 Million USD | -867.508% |
| TRxADE HEALTH, Inc. | 7.1 Million USD | -2478.467% |
| PetMed Express, Inc. | 1.45 Million USD | -12497.799% |
| Walgreens Boots Alliance, Inc. | 9.55 Billion USD | 98.083% |